Erin E. Wilhelm

发表

Cognitive Rehabilitation Therapy for Traumatic Brain Injury: Evaluating the Evidence

I. Shoulson, R. Koehler, Erin E. Wilhelm, 2013 .

A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data.

I. Shoulson, V. Aroda, H. Hassanzadeh, 2017, Journal of diabetes and its complications.

Reasons for Premature Conclusion of Late Phase Clinical Trials: An Analysis of ClinicalTrials.gov Registered Phase III Trials

I. Shoulson, Erin E. Wilhelm, D. Guinn, 2020, Therapeutic Innovation & Regulatory Science.

Inaugural Conference on Incorporating Patient-Reported Outcomes and Patient Preference Information into Clinical Research, Clinical Care, and Risk-Benefit Assessments for Neurodegenerative Diseases

John P. Creveling, P. Tariot, E. Dorsey, 2017, The Patient - Patient-Centered Outcomes Research.

Emerging good practices for Translatability Assessment (TA) of Patient-Reported Outcome (PRO) measures

Steven H. Blum, Clayon B Hamilton, Lara B. Russell, 2018, Journal of Patient-Reported Outcomes.

Assessing function of electronic health records for real-world data generation

S. Khozin, Erin E. Wilhelm, G. Liebérman, 2018, BMJ Evidence-Based Medicine.

Climate Change, Human Health, and Biomedical Research: Analysis of the National Institutes of Health Research Portfolio

Sheila A. Newton, J. Balbus, C. Jessup, 2013, Environmental health perspectives.

Approaches and costs for sharing clinical research data.

Ira Shoulson, E. Oster, I. Shoulson, 2014, JAMA.

I-SPY 2 Breast Cancer Trial as a Model for Innovation in Alzheimer Disease Therapies.

I. Shoulson, Erin E. Wilhelm, Mindi F Messmer, 2017, JAMA neurology.

Reasons for Premature Conclusion of Late Phase Clinical Trials: An Analysis of ClinicalTrials.gov Registered Phase III Trials

I. Shoulson, Erin E. Wilhelm, D. Guinn, 2019, Therapeutic innovation & regulatory science.